Tuesday
August 12, 2025
7:05 AM ET
Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Friday
July 11, 2025
9:30 AM ET
Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants
Friday
July 11, 2025
6:01 AM ET
Milestone Pharmaceuticals Announces Proposed Public Offering
Wednesday
May 14, 2025
7:04 AM ET
Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
Thursday
March 13, 2025
7:08 AM ET
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Regulatory and Corporate Update